{"url_path":"/sec/petv/8-k/2026-06-25/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1512922/0001493152-26-030193-index.html","accession_number":"0001493152-26-030193","cik":"0001512922","ticker":"PETV","issuer_name":"PetVivo Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1512922/0001493152-26-030193-index.html","primary_entity_key":"0001512922","primary_entity_name":"PetVivo Holdings, Inc."},"word_count":522,"has_tables":true,"body_markdown":"**Item\n7.01. Regulation FD Disclosure**\n\n** **\n\nOn\nJune 24, 2026, the Company issued a press release announcing the entry into the Agreement with PBM, a copy of which is attached hereto\nas Exhibit 99.1.\n\n \n\nThe\ninformation in this Item 7.01 of this report, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section\n18 of the Securities Exchange Act of 1934, as amended (“**Exchange Act**”)*,* or otherwise subject to the\nliabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933,\nas amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.\n\n \n\nThis\nCurrent Report on Form 8-K contains forward-looking statements within the meaning of the “safe harbor” provisions of the\nPrivate Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the Company’s entry into\nthe Agreement and Plan of Merger with PiezoBioMembrane, Inc. (“PBM”), the anticipated completion of the merger and related\ntransactions, the expected ownership and operation of PBM through Cosmeta Corp., the anticipated acquisition and development of PBM’s\nintellectual property, technology platform, product candidates, biomaterials, and related assets, the achievement of development and\nregulatory milestones, the advancement and commercialization of functional biomaterials and regenerative medicine technologies, the potential\nexpansion of such technologies into additional indications and applications, the timing and results of development, regulatory, manufacturing,\ncommercialization, and business activities, and potential market opportunities associated with the Company’s existing and future\nproduct candidates and technology platforms.\n\n \n\nAll\nstatements other than statements of historical fact are statements that could be deemed forward-looking statements. Although the Company\nbelieves that the expectations reflected in such forward-looking statements are reasonable, the Company cannot guarantee future events,\nresults, actions, levels of activity, performance, achievements, or the successful completion of the merger transaction. Forward-looking\nstatements are subject to risks and uncertainties that may cause the Company’s actual activities or results to differ materially\nfrom those expressed in any forward-looking statement, including, without limitation, risks relating to the satisfaction of closing conditions\nunder the Merger Agreement, the Company’s ability to complete the required financing, the successful integration and operation\nof PBM within Cosmeta Corp., the development and commercialization of acquired technologies and product candidates, the receipt and timing\nof regulatory approvals, clearances, authorizations, or other regulatory actions, the timing and results of preclinical and clinical\ndevelopment activities, manufacturing and supply chain challenges, the Company’s ability to achieve development objectives, the\nprotection and enforcement of intellectual property rights, the ability to retain key personnel and consultants, the acceptance of new\ntechnologies by customers and strategic partners, the size and development of potential markets, and the Company’s commercial collaborations\nand strategic relationships, as well as other risks and uncertainties described under the heading “Risk Factors” in documents\nfiled by the Company from time to time with the Securities and Exchange Commission.\n\n \n\nThese\nforward-looking statements speak only as of the date of this Current Report on Form 8-K, and the Company undertakes no obligation to\nrevise or update any forward-looking statements to reflect events or circumstances occurring after the date hereof, except as required\nby applicable law."}